摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-乙酰基-4-碘萘 | 91493-16-2

中文名称
1-乙酰基-4-碘萘
中文别名
——
英文名称
1-acetyl-4-iodonaphthalene
英文别名
4-iodo-1-acetonaphtone;4-Iod-1-aceto-naphthon;1-(4-Iodonaphthalen-1-yl)ethanone
1-乙酰基-4-碘萘化学式
CAS
91493-16-2
化学式
C12H9IO
mdl
——
分子量
296.107
InChiKey
MLVGDKVJDNKSGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    72-73 °C(Solv: ethanol (64-17-5))
  • 沸点:
    386.8±25.0 °C(Predicted)
  • 密度:
    1.671±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    1-乙酰基-4-碘萘 、 sodium hydroxide 作用下, 反应 2.67h, 生成 4-碘萘-1-羧酸
    参考文献:
    名称:
    Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: Steric and electronic effects of 4- and 8-halogenated naphthoyl substituents
    摘要:
    To develop SAR at both the cannabinoid CB1 and CB2 receptors for 3-(1-naphthoyl)indoles bearing moderately electron withdrawing substituents at C-4 of the naphthoyl moiety, 1-propyl and 1-pentyl-3-(4-fluoro, chloro, bromo and iodo-1-naphthoyl) derivatives were prepared. To study the steric and electronic effects of substituents at the 8-position of the naphthoyl group, the 3-(4-chloro, bromo and iodo-1-naphthoyl) indoles were also synthesized. The affinities of both groups of compounds for the CB1 and CB2 receptors were determined and several of them were evaluated in vivo in the mouse. The effects of these substituents on receptor affinities and in vivo activity are discussed and structure-activity relationships are presented. Although many of these compounds are selective for the CB2 receptor, only three JWH-423, 1-propyl-3-(4-iodo-1-naphthoyl)indole, JWH-422, 2-methyl-1-propyl-3-(4-iodo-1-naphthoyl) indole, the 2-methyl analog of JWH-423 and JWH-417, 1-pentyl-3-(8-iodo-1-naphthoyl)indole, possess the desirable combination of low CB1 affinity and good CB2 affinity. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.01.038
  • 作为产物:
    描述:
    1-碘萘乙酰氯 在 aluminum (III) chloride 作用下, 以 二氯甲烷 为溶剂, 反应 120.17h, 以55%的产率得到1-乙酰基-4-碘萘
    参考文献:
    名称:
    Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: Steric and electronic effects of 4- and 8-halogenated naphthoyl substituents
    摘要:
    To develop SAR at both the cannabinoid CB1 and CB2 receptors for 3-(1-naphthoyl)indoles bearing moderately electron withdrawing substituents at C-4 of the naphthoyl moiety, 1-propyl and 1-pentyl-3-(4-fluoro, chloro, bromo and iodo-1-naphthoyl) derivatives were prepared. To study the steric and electronic effects of substituents at the 8-position of the naphthoyl group, the 3-(4-chloro, bromo and iodo-1-naphthoyl) indoles were also synthesized. The affinities of both groups of compounds for the CB1 and CB2 receptors were determined and several of them were evaluated in vivo in the mouse. The effects of these substituents on receptor affinities and in vivo activity are discussed and structure-activity relationships are presented. Although many of these compounds are selective for the CB2 receptor, only three JWH-423, 1-propyl-3-(4-iodo-1-naphthoyl)indole, JWH-422, 2-methyl-1-propyl-3-(4-iodo-1-naphthoyl) indole, the 2-methyl analog of JWH-423 and JWH-417, 1-pentyl-3-(8-iodo-1-naphthoyl)indole, possess the desirable combination of low CB1 affinity and good CB2 affinity. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.01.038
点击查看最新优质反应信息

文献信息

  • Allosteric adenosine receptor modulators
    申请人:——
    公开号:US20010047008A1
    公开(公告)日:2001-11-29
    The present invention relates to compounds of formulas (IA) and (IB): 1 the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as allosteric adenosine receptor modulators for uses including protection against hypoxia and ischemia induced injury and treatment of adenosine-sensitive cardiac arrhythmias.
    本发明涉及以下化合物的公式(IA)和(IB):其制备、药物配方以及在医学中作为变构腺苷受体调节剂的用途,包括保护免受缺氧和缺血引起的损伤以及治疗对腺苷敏感的心律失常。
  • Rajasekaran, Kasi; Gnanasekaran, Chinnasamy, Journal of the Chemical Society. Perkin transactions II, 1987, p. 263 - 266
    作者:Rajasekaran, Kasi、Gnanasekaran, Chinnasamy
    DOI:——
    日期:——
  • RAJASEKARAN KASI; GNANASEKARAN CHINNASAMY, J. CHEM. SOC. PERKIN TRANS.,(1987) N 3, 263-266
    作者:RAJASEKARAN KASI、 GNANASEKARAN CHINNASAMY
    DOI:——
    日期:——
  • EP1401441A4
    申请人:——
    公开号:EP1401441A4
    公开(公告)日:2006-09-06
  • ALLOSTERIC ADENOSINE RECEPTOR MODULATORS
    申请人:King Pharmaceuticals Research and Development Inc.
    公开号:EP1401441A2
    公开(公告)日:2004-03-31
查看更多